Global Spirulina Market to Reach USD 238.3 Million by 2022

Published On: April 22, 2017

The global spirulina market will grow at a CAGR of 7.1% from 2017 to 2022 to reach USD 238.3 million by 2022, according to the latest publication from Meticulous Research™. The global spirulina market is driven by the growing demand for natural food colors, increasing vegetarianism, stringent regulations regarding the inclusion of synthetic colors and flavors, and growing malnutrition across the globe. However, low awareness of the benefits of spirulina and challenges associated with the production of spirulina is expected to hinder the growth of the global spirulina market to some extent.

The global spirulina market is mainly segmented by form (powder, tablet, capsules, and flakes), application (food & beverages, nutraceutical, pharmaceutical, veterinary cosmetic, and others), and geography. Based on form, powdered spirulina held the largest share of the market in 2016 and is expected to dominate global spirulina market during the forecast period, owing to increasing usage of the powder form of spirulina in food.

Based on application, food & beverages accounted for the major share of the global spirulina market in 2016, owing to the growing health concerns of aging population in various countries, a growing desire for natural alternatives to traditional pharmaceutical products, and increased awareness among consumers on the link between nutrition and health.

Geographically, this market is segmented into North America (U.S. and Canada), Europe (Germany, France, U.K., Netherlands, Italy, and RoE), Asia Pacific (China, India, Japan, and RoAPAC), Latin America, and Middle East & Africa. North America commanded the largest share in the global spirulina market in 2016, followed by Europe and Asia-Pacific. The large share of this market is mainly attributed growing awareness among consumers for natural food products, rising regulations against synthetic colors, growth of subsidiary industries like cosmetics and bio fertilizers, and increasing preference for plant protein sources. However, Asia Pacific region are expected to witness significant growth during the forecast period due to increasing investments, increasing government initiatives, and growing numbers of national and provincial level research projects on microalgae classification, breeding and preservation technology in the region.

Which are the high growth market segments in terms of form, application, and regions/countries?

What is the historical market for spirulina across the globe?

What are the market forecasts and estimates from the period 2015-2022?

What are the major drivers, restraints, and opportunities in the global spirulina market?

Who are the major players in the global spirulina market and what share of the market do they hold?

Who are the major players in various countries and what share of the market do they hold?

What are the geographical trends and high growth regions/ countries?

Who are the local emerging players in the global spirulina market and how do they compete with the global players?

About Meticulous Research™

Meticulous Research™ is founded in 2010 and incorporated as Meticulous Market Research Pvt. Ltd. in 2013 as a private limited company under the Companies Act, 1956. Since its incorporation, the company has become the leading provider of premium market intelligence in North America, Europe, Asia-Pacific, Latin America, and Middle East & Africa.

With the meticulous primary and secondary research techniques, we have built strong capabilities in data collection, interpretation, and analysis of data including qualitative and quantitative research with the finest team of analysts. We design our meticulously analyzed intelligent and value-driven syndicate market research reports, custom studies, quick turnaround research, and consulting solutions to address business challenges of sustainable growth. Meticulous Research™ produces global reports and custom studies for North America, Europe, Latin America, Asia¬-Pacific, and Middle East and Africa regions. These reports are used by our clients for marketing and strategic planning in various sectors.

Select License Type

Single User -

Multiple User -

Corporate User -

License Details

Single User:

With the help of Single User License, only an individual can use our report either electronically or online. The right to use of the report should be confined only to one authorized computer. Upon buying single user license, buyer must provide the names and email ids of the authorized users of this report.

Multi Users:

Multi-User license permits to access the report from five authorized computers. It does not permit you to share the report with other divisions and subsidiaries of the same company. Upon buying multi-user license, buyer must provide the names and email ids of the authorized users of this report.

Corporate User

With corporate use license, the complete or part of the content of the report can be shared or made available to other persons, other divisions and subsidiaries of same company. However, reproduction or redistribution of the report is prohibited without the prior permission of Meticulous Research.

Dating back from 1970’s, it is believed that use of barcode technology in various healthcare settings has reduced the medication errors and the cost incurred in rehabilitating the patient after the wrong treatment. The adoption of such advanced technologies in the healthcare sector will drastically enhance the operations of hospitals or other healthcare systems.

According to the Journal of Patient Safety, around 400,000 deaths occur each year in the U.S. only. It also reveals that each year preventable adverse events (PAEs) lead to the death of 210,000-400,000 patients who seek care at a hospital.

Corn is the leading source of starch extraction. The corn plant has large capacity for efficiently converting large amounts of radiant energy from the sun into stable chemical energy. This energy is stored as cellulose, oil, and starch in the corn plant and in the corn kernel. The corn plant is also one of nature's greatest multipliers.

Pharmaceutical industry has grown in leaps and bounds during the last three to four decades. Initial emphasis on validation of tablets started across the industry globally sometime in late sixties or early seventies.